Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?”

Detalles Bibliográficos
Autores principales: Matsuura, Hiroaki, Fujiwara, Keiichi, Omori, Hiroki, Onishi, Kiriko, Kuribayashi, Tadahiro, Mitsumune, Sho, Takigawa, Yuki, Kudo, Kenichiro, Sato, Akiko, Sato, Ken, Shibayama, Takuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381187/
https://www.ncbi.nlm.nih.gov/pubmed/33583909
http://dx.doi.org/10.2169/internalmedicine.6952-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381187/
https://www.ncbi.nlm.nih.gov/pubmed/33583909
http://dx.doi.org/10.2169/internalmedicine.6952-20

Ejemplares similares